Market Overview

UPDATE: ISI Group Initiates Allscripts Healthcare Solutions with Market Weight, $11 PT on Product Development Overhang

Share:
Related MDRX
Top 4 Mid-Cap Stocks In The Application Software Industry With The Highest EPS Growth Forecast For Next Year
Benzinga's Top Downgrades
Allscripts -8.2% on revenue miss, bookings drop, soft sales guidance (Seeking Alpha)

ISI Group initiated its coverage on Allscripts Healthcare Solutions (NASDAQ: MDRX) with a rating of Market Weight and a price target of $11.

ISI Group noted, "Our thesis for MDRX is based on continued issues related to product development efforts and the overhang that this creates on bookings growth, the potential for renewed cross-sell opportunities following the product revamp, and the trade-off between cost synergies and increased R&D spending limiting margin expansion opportunities. However, with the recent sell-off in the stock, we think that the appropriate risk level is assumed in valuation and MDRX continues to have one of the largest installed bases in the market."

Allscripts Healthcare Solutions closed at $10.21 on Wednesday.

Latest Ratings for MDRX

DateFirmActionFromTo
Feb 2015BarclaysMaintainsEqualweight
Feb 2015Leerink SwannDowngradesOutperformMarket Perform
Jan 2015JP MorganMaintainsOverweight

View More Analyst Ratings for MDRX
View the Latest Analyst Ratings

Posted-In: ISI GroupAnalyst Color Initiation Intraday Update Analyst Ratings

 

Related Articles (MDRX)

Around the Web, We're Loving...

Get Benzinga's Newsletters

Benzinga PRO content